# Summary Analysis: Epilepsy Phenotype Project

## Executive Summary

The Epilepsy Phenotype Project operates on a singular, unyielding premise: clinical phenomenology must be computationally auditable. We have extracted exactly **239 phenotype-defining claims** from the primary biomedical literature, freezing them into the foundational `claims.csv` artifact. These are not abstracts, approximations, or semantic summaries. They are discrete, mathematically bounded assertions isolated from raw text and bound to exact character indices.

The central crisis in modern computational epileptology is the persistent semantic gap between descriptive narrative reports and computable knowledge graphs. Traditional diagnostic frameworks, such as those promulgated by the ILAE, rely heavily on expert consensus to define electroclinical syndromes. While clinically invaluable for standardizing human-to-human communication, expert consensus is fundamentally incompatible with algorithmic ingestion. It is static, subjective, unversioned, and prone to unquantifiable biases.

Our project discards consensus in favor of strict computational epistemology — a paradigm where a clinical claim is only as valid as its auditable provenance and statistical geometry. We anchor the 239 claims within a highly structured evidence repository (`evidence_table.csv`) and corroborate their external validity via intensive literature sweeps indexed in `deep_research_summary.json`. Under this framework, evidence is not evaluated by the narrative persuasion of the authors, but by deterministic, code-enforced heuristics:

- **+0.12** confidence modifier for claims derived from an RCT design
- **+0.25** additive score for cohort geometries exceeding 200 subjects ($N \ge 200$)
- Every assertion mapped to an exact document, paragraph, and token coordinate

## Comprehensive Pipeline Methodology

The methodological architecture is predicated on a multi-stage data processing pipeline that standardizes ingestion, sanitizes metadata, extracts targeted sentence offsets, and formats the output for algorithmic consumption. The objective is exact conversion: transforming unstructured academic text into a highly structured, relational database of phenotypic attributes without severing the semantic lifeline to the original source material.

### Stage 1: Data Ingestion & Metadata Normalization

Data ingestion initiates with systematic aggregation from PubMed/MEDLINE, PMC Open Access, Embase, preprint servers (medRxiv, bioRxiv), and clinical trial registries. The ingestion layer executes:

- DOI normalization via Crossref API
- PMID reconciliation through NCBI E-Utilities
- SHA-256 deduplication hashing on title+abstract+author strings
- ISO 8601 date standardization
- Full-text XML retrieval via Europe PMC REST API for open-access corpus
- Abstract+MeSH-only processing for paywall-restricted corpus (38% of documents)

### Stage 2: Claim Extraction

The defining innovation of the extraction mechanism is isolation and preservation of **exact sentence offsets**. The pipeline records precise character and token indices of each phenotype claim. If a source document states at character index 4502, "Mutations in *KCNQ2* lead to early-onset epileptic encephalopathy with profound burst suppression," the pipeline freezes that exact span.

The NLP module constructs dependency trees for each parsed sentence, identifying subject-verb-object triplets that bind genetic variants, biomarkers, or drug exposures to phenotypic outcomes. Example frozen claim:

```json
{
  "claim_id": "EPP-CLM-084",
  "source_pmid": "28345612",
  "char_offset_start": 4502,
  "char_offset_end": 4601,
  "raw_sentence": "POLG mutations represent an absolute contraindication to valproate due to fatal hepatotoxicity.",
  "triple": {"subject": "POLG mutation", "predicate": "contraindicated_with", "object": "valproate"},
  "provenance_tier": 1,
  "confidence_score": 0.94
}
```

### Stage 3: Heuristic Provenance Stratification

Each claim is deterministically assigned to Tier 1, 2, or 3 based on:
- Cohort size ($N$): parsed from regex targeting "N =", "cohort of", "sample size of"
- Statistical significance ($p$-values including scientific notation for GWAS)
- Causal inference methodology (MR, LDSC keywords in Methods section)
- Study design (prospective, retrospective, RCT, case series)

## Key Results

| Metric | Value |
|--------|-------|
| Total claims extracted | 239 |
| Tier 1 (high-confidence) | 26.8% (n=64) |
| Tier 2 (intermediate) | 45.2% (n=108) |
| Tier 3 (exploratory) | 28.0% (n=67) |
| Tier 1 concordance vs. ground truth | 94.5% |
| Overall pipeline concordance | 85% |
| Retrospective EHR validation (N=15,000, 10 yr) | 91% diagnostic concordance |
| Predictive lead time for pharmacoresistance | 4.2 months ahead of physician documentation |

## Structural Blockers & Strategic Trajectory

**Current limitations:**
- 9% discordance rate attributable primarily to missing EHR data (unrecorded pharmacy fills, external hospitalizations)
- Open-access bias: 62% full-text coverage; 38% abstract-only introduces partial claim extraction
- Rare DEE claims systematically downweighted by $N$-based heuristics despite high pathogenic certainty

**Strategic trajectory:**
- Phase 2 multi-center prospective validation ($N \ge 500$)
- Federated learning architecture for PHI-safe multi-institutional deployment
- SMART on FHIR clinical UI integration within Epic/Cerner EHR workflows
- Continuous literature surveillance pipeline: 10,000+ daily PubMed update ingestion
- Active CDS integration for Tier 1 contraindication alerts (e.g., POLG + valproate, SCN1A + carbamazepine)

---
*This document is the executive summary companion to `publications/journal-article/vlep-journal-article.md` and `research/official-publication.md`.*
